冠状动脉微血管功能障碍:专注于病理生理机制和最新的诊断技术.
Gianluca Mincione1, Matteo Maurina2, Alice Benedetti3
1Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
概括
冠状动脉微血管功能障碍会影响没有明显阻塞的患者. 这篇评论探讨了它的原因,新的诊断工具,以及基于患者内型的个性化治疗方法.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
- 诊断成像 诊断成像 诊断成像
背景情况:
- 传统的干预心脏病学专注于心上冠状动脉外皮病变.
- 一部分患者表现出类似于上心脏病的症状,但缺乏血管学证据.
- 这些病例越来越多地被认为是冠状动脉微血管功能障碍的表现.
研究的目的:
- 审查冠状动脉微血管功能障碍的病理生理学.
- 为突出这一疾病的新型诊断方法.
- 讨论针对特定内型型的新兴治疗策略.
主要方法:
- 病理生理学,诊断和治疗学的文献综述.
- 专注于内型特异性治疗策略.
- 探索超越传统血管学之外的新诊断方式.
主要成果:
- 冠状动脉微血管功能障碍是一个独特的临床实体.
- 诊断技术的进步正在提高检测率.
- 基于内型的个性化治疗策略正在显示出希望.
结论:
- 冠状动脉微血管功能障碍是缺血症状的重要原因.
- 早期和准确的诊断对于有效的管理至关重要.
- 根据内型型量身定制治疗,为改善患者的治疗结果提供了一条道路.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
42
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
42
Coronary Artery Disease II: Pathophysiology
42
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
Coronary Artery Disease I: Introduction
69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
Mitral Stenosis II: Clinical features and Diagnostic Tests
39
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
39


